Guardant Health, Inc. (GH)
NASDAQ: GH · IEX Real-Time Price · USD
17.96
+0.27 (1.53%)
At close: Mar 27, 2024, 4:00 PM
18.20
+0.24 (1.34%)
Pre-market: Mar 28, 2024, 4:01 AM EDT

Guardant Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Net Income
-479.45-654.59-405.67-253.78-75.65-85.06-89-46.14
Depreciation & Amortization
42.8835.9622.2721.6315.827.145.213.69
Share-Based Compensation
90.7694.69151.45144.1116.956.853.671.97
Other Operating Activities
20.83214.4822.93-15.89-4.26-1.112.113.77
Operating Cash Flow
-324.98-309.46-209.02-103.93-47.13-72.19-72.24-36.71
Capital Expenditures
-20.49-77.46-75.04-54.06-21.22-20.2-6.68-1.77
Acquisitions
0000-7.33000
Change in Investments
859.21227.2811.88-563.03-288.96-132.83-161.4327.97
Other Investing Activities
1.53----0.07--2.3-
Investing Cash Flow
840.25149.82-63.16-617.09-317.57-153.03-170.4226.2
Share Issuance / Repurchase
503.6811.9417.87371.22367.74252.56-6.470.17
Debt Issued / Paid
0001,133-0.13-0.44-26.09-0.38
Other Financing Activities
-26.3-201.03-84.69-93.49-0.3141.05314.2140.05
Financing Cash Flow
477.38-189.09-66.821,410367.3293.16281.6639.84
Exchange Rate Effect
-0.91-1.6-1.690.460.08000
Net Cash Flow
991.74-350.34-340.69689.752.6867.9539.0129.33
Free Cash Flow
-345.46-386.92-284.05-157.99-68.35-92.39-78.92-38.48
Free Cash Flow Margin
-61.26%-86.07%-76.02%-55.10%-31.88%-101.93%-158.33%-152.39%
Free Cash Flow Per Share
-3.08-3.79-2.80-1.62-0.75-3.04-6.27-2.95
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).